The largest database of trusted experimental protocols

14 protocols using anti cd3 apc efluor780

1

Quantifying CD69 Expression in Jurkat T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
J.RT3-T3.5 2B9 cells (1 million) were transduced by direct addition of 1 mL HEK293T supernatant (see S1 Methods) and incubated for 72 h. Transduced J.RT3-T3.5 2B9 cells and co-cultures of these cells with antigen-presenting cells (100,000 cells each) were incubated in 96-well plates (Greiner Bio-one) for approximately 16 h. Supernatants containing Jurkat cells were removed and the cells pelleted. Cells were washed once with PBS with 0.1% fetal bovine serum (Gibco) before incubation with anti-CD69-PE (12-0699-42, Thermo Fisher Scientific), anti-CD3-APC-eFluor780 (47-0038-42, Thermo Fisher Scientific), and anti-CD8-VioBlue (130-110-684, Miltenyi Biotec) for 30 min at 4°C. Cells were pelleted and washed once with PBS with 0.1% fetal bovine serum. Cells were pelleted and resuspended in 7-AAD solution (51–6898, BD Pharmingen) before data were acquired on a Miltenyi MACSQuant flow cytometer. Data were analyzed using FlowJo v10.6.0 (FlowJo LLC). CD69-positive events were quantified upon gating on lymphocytes (SSC-A vs FSC-A), singlets (FSC-A vs FSC-H), live cells (7-AAD vs FSC-A), and CD8- and CD3-positive cells (S1 Fig).
+ Open protocol
+ Expand
2

Single-cell isolation of SARS-CoV-2 reactive B cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cells from PBMCs of uninfected controls or of COVID-19 convalescent individuals were enriched using the pan-B-cell isolation kit according to manufacturer’s instructions (Miltenyi Biotec, 130-101-638). The enriched B cells were subsequently stained in FACS buffer (PBS + 2% FCS + 1mM EDTA) with the following antibodies/reagents (all at 1:200 dilution) for 30 min on ice: anti-CD20-PE-Cy7 (BD Biosciences, 335828), anti-CD14-APC-eFluor 780 (Thermo Fischer Scientific, 47-0149-42), anti-CD16-APC-eFluor 780 (Thermo Fischer Scientific, 47-0168-41), anti-CD3-APC-eFluor 780 (Thermo Fischer Scientific, 47-0037-41), anti-CD8-APC-eFluor 780 (Invitrogen, 47-0086-42), Zombie NIR (BioLegend, 423105), as well as fluorophore-labeled ovalbumin (Ova) and peptides. Live single Zombie-NIRCD14CD16CD3CD8CD20+Ovapeptide-PE+peptide-AF647+ B cells were single-cell sorted into 96-well plates containing 4 μl of lysis buffer (0.5× PBS, 10 mM DTT, 3,000 units/ml RNasin Ribonuclease Inhibitors [Promega, N2615]) per well using a FACS Aria III, and the analysis was performed with FlowJo software. The isolation of SD1-enriched B cells was performed similarly, except that sorted cells were live single Zombie-NIRCD14CD16CD3CD8CD20+OvaRBDSD1-RBD-PE+SD1-RBD-AF647+. The gating strategy is shown in fig. S1C.
+ Open protocol
+ Expand
3

Comprehensive Immunophenotyping of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stained with LIVE/DEAD reagent (Invitrogen, MA, USA), anti-CD3 APC-eFluor780 (ThermoFisher, MA, USA), anti-CD4-BUV395, anti-CD8-BV786, anti-CD27-BUV737, anti-CD45RA-APC-H7 and anti-HLADR-BV650 (BioLegend, CA, USA), anti-CD161-PE, and anti-ϒδ TCR-PE-CY7 (BD Life Sciences, NJ, USA) and anti-Vδ1-FITC (Miltenyi Biotec, Bergisch Gladbach, Germany) (see Supplemental Table 1). Data were acquired on an LSR-Fortessa II, and BD FACSDiva Software (BD Life Sciences, NJ, USA).
+ Open protocol
+ Expand
4

Enrichment and Single-Cell Sorting of SARS-CoV-2 Reactive B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cells from PBMCs of uninfected controls or of COVID-19 convalescent individuals were enriched using the pan-B-cell isolation kit according to manufacturer’s instructions (Miltenyi Biotec, 130–101-638). The enriched B cells were subsequently stained in FACS buffer (PBS + 2% FCS + 1 mM EDTA) with the following antibodies/reagents (all at 1:200 dilution) for 30 min on ice: anti-CD20-PE-Cy7 (BD Biosciences, 335828), anti-CD14-APC-eFluor 780 (Thermo Fischer Scientific, 47–0149-42), anti-CD16-APC-eFluor 780 (Thermo Fischer Scientific, 47–0168-41), anti-CD3-APC-eFluor 780 (Thermo Fischer Scientific, 47–0037-41), anti-CD8-APC-eFluor 780 (Invitrogen, 47–0086-42), Zombie NIR (BioLegend, 423105), as well as fluorophore-labeled ovalbumin (Ova) and peptides. Live single Zombie-NIRCD14CD16CD3CD8CD20+Ovapeptide-PE+peptide-AF647+ B cells were single-cell sorted into 96-well plates containing 4 μl of lysis buffer (0.5× PBS, 10 mM DTT, 3,000 units/ml RNasin Ribonuclease Inhibitors [Promega, N2615]) per well using a FACS Aria III, and the analysis was performed with FlowJo software. The isolation of SD1-enriched B cells was performed similarly, except that sorted cells were live single Zombie-NIRCD14CD16CD3CD8CD20+OvaRBDSD1-RBD-PE+SD1-RBD-AF647+. The gating strategy is shown in fig. S1C.
+ Open protocol
+ Expand
5

Single-cell sorting of B cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
B cells from PBMCs of uninfected controls or of COVID-19 convalescent individuals were enriched using the pan-B-cell isolation kit according to manufacturer’s instructions (Miltenyi Biotec, 130-101-638). The enriched B cells were subsequently stained in FACS buffer (PBS + 2% FCS + 1mM EDTA) with the following antibodies/reagents (all at 1:200 dilution) for 30 min on ice: anti-CD20-PE-Cy7 (BD Biosciences, 335828), anti-CD14-APC-eFluor 780 (Thermo Fischer Scientific, 47-0149-42), anti-CD16-APC-eFluor 780 (Thermo Fischer Scientific, 47-0168-41), anti-CD3-APC-eFluor 780 (Thermo Fischer Scientific, 47-0037-41), anti-CD8-APC-eFluor 780 (Invitrogen, 47-0086-42), Zombie NIR (BioLegend, 423105), as well as fluorophore-labeled ovalbumin (Ova) and peptides. Live single Zombie-NIRCD14CD16CD3CD8CD20+Ovapeptide-PE+peptide-AF647+ B cells were single-cell sorted into 96-well plates containing 4 μl of lysis buffer (0.5× PBS, 10 mM DTT, 3,000 units/ml RNasin Ribonuclease Inhibitors [Promega, N2615]) per well using a FACS Aria III, and the analysis was performed with FlowJo software. The isolation of SD1-enriched B cells was performed similarly, except that sorted cells were live single Zombie-NIRCD14CD16CD3CD8CD20+OvaRBDSD1-RBD-PE+SD1-RBD-AF647+. The gating strategy is shown in fig. S1C.
+ Open protocol
+ Expand
6

Isolation and Characterization of B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen lymph node (LN) cell suspensions collected from macaques vaccinated with VLP-RC1–4fill12 (link) were thawed and incubated in FACS buffer (1xPhosphate-buffered saline (PBS), 2% calf serum, 1 mM EDTA) with the following anti human antibodies at 1:200 dilution: anti CD3-APC-eFluor 780 (Invitrogen, 47-0037-41), anti CD14-APC-eFluor 780 (Invitrogen, 47-0149-42), anti CD16-APC-eFluor 780 (Invitrogen, 47-0168-41), anti CD8-APC-eFluor 780 (Invitrogen, 47-0086-42), anti CD20-PE-Cy7 (BD biosciences, 335793), and anti CD38 FITC (Stem Cell, 60131FI) and the LIVE/DEAD marker (Biolegend, 77184) at 1:400 dilution. Avi-tagged and biotinylated baits conjugated to fluorophore labeled streptavidin were added to the antibody mixture and incubated with the LN cells for 30 min. Single B cells were sorted into individual wells of a 96-well plates containing 5 μl of TCL lysis buffer (Qiagen, 1031576) and 1% beta-mercaptoethanol per well using a FACS Aria III (Becton Dickinson). The cell lysates were stored at −80°C or immediately used for subsequent mRNA purification.
To interrogate the B cell receptor specificity of the retrogenic B cells, the transduced B cells were incubated with Avi-tagged-biotinylated RC1 in complex with fluorophore labeled streptavidin for 30 min on ice. Alternatively, cells were incubated with fluorophore labeled streptavidin in the absence of RC1 for 30 min on ice.
+ Open protocol
+ Expand
7

Quantification of Cross-Reactive T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
This procedure was performed using modified versions of protocols described previously (12 , 13 (link)). Briefly, human PBMCs were stimulated with 17.7 μg/ml of TT lysate (MassBiologics, University of Massachusetts Medical School, MA) for 5-7 days. Spleen cells from DR3 mice immunized with protein or peptide were harvested 10-14 days post immunization. Human PBMCs were stained with 1 μg of DR3 tetramer for 3-4 hours at 37°C; and mouse spleen cells were stained for 2 hours. After tetramer staining, the cells were washed in PBS containing 2% FCS (FACS buffer) and surface markers were detected by anti-CD4-FITC (Biolegend, San Diego, CA) and anti-CD3-APCeFluor™780 (Invitrogen, Waltham, MA) for human cells and anti-CD4-FITC and anti-CD3-APC/Fire™750 (Biolegend, San Diego, CA) for mouse cells on ice for 30 minutes after Fc blocking. Cells were analyzed by the BD LSR Fortessa™ Cell Analyzer (BD, Franklin Lakes, NJ). When determining the percentage of single epitope reactive T cells from dual tetramer staining as seen in Figure 6, for SmD66-80, the percentage of single SmD66-80 tetramer positive T cells was the sum of cells in Q1 and Q2; for the ABC247-261 Mimic and TT peptides, the percentage of single Clostridium tetani epitope tetramer positive T cells was the sum of cells in Q2 and Q3. Cross-reactive T cells between SmD66-80 and Clostridium tetani epitopes were detected in Q2.
+ Open protocol
+ Expand
8

Flow Cytometric Analysis of Activated CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Activated CD4+ T cells were stained with the following mAb: anti-CD3-APC-eFluor780, anti-CD4-APC, anti-CD25-PE, anti-Foxp3-Pac blue (eBioscience), and anti-pS6 (Ser235)-FITC (Cell Signaling Technology) using buffers from eBioscience. The stained cells were analyzed on a LSR II flow cytometer and data were analyzed with the Flowjo software package.
+ Open protocol
+ Expand
9

Quantifying Chemokine Receptor Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vehicle- and PTX-treated cells were separately stained with anti-CCR6, followed by anti-mouse IgG-APC as previously described. Cells were washed two times in Labelling Buffer. Vehicle-treated cells were stained with anti-CD3 APC-eFluor780 (eBioscience, clone UCHT1, Hatfield, UK) and PTX-treated cells were stained with anti-CD3 AlexaFluor700 (eBioscience, clone UCHT1) diluted in Labelling Buffer and incubated for 15 minutes at 37°C. Cells were washed three times in RT HBSS. An equivalent number (determined by Trypan Blue Stain) of vehicle- and PTX-treated cells were combined to a final density of 1x106 cells/ml and loaded with 1 μM Fura Red, AM as previously described.
+ Open protocol
+ Expand
10

Multiparameter Analysis of CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
533IYSTVASSL541 (IVL533-541)-tetramer was bought from MBL (cat. NO.TS-M520-1), anti-CD8α depletion antibody (clone: YTS 169.4). Rat IgG2b isotype antibody (clone: LTF-2) was purchased from Bio X Cell. Antibodies for flow cytometry included anti-CD3-APC-eFluor780 (clone: 17A2; eBioscience), anti-CD4-Pacific Blue (clone: GK1.5; BioLegend), anti–CD8α-PerCP/Cy5.5 (clone: 53–6.7; BioLegend), anti-CD11a-PE/Cy7 (clone: 2D7; BD Bioscience), anti–CD44-Alexa Fluor 700 (clone: IM7; BioLegend), anti-CD45-APC-eFluor780 (clone:30-F11;Biolegend), anti-CD62L-eVolve 605 (clone: MEL-14; eBioscience), anti-CD127-PE & PE/Cy7 (clone: A7R34; BioLegend), anti-KLRG1-FITC & BV510 (clone: 2F1/KLRG1; BioLegend), anti-CD103-APC (clone: 2E7; BioLegend), anti-CD69-FITC (clone: H1.2F3; BioLegend) and anti-IFNγ-APC (clone: XMG1.2; BioLegend), anti-Eomes-PE & PE/Cy7 (clone: Dan11mag; eBioscience).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!